Markets › United States › NAS › DRMAW

Dermata Therapeutics Inc

NAS:DRMAWHealthcare

——At close · Market cap — · Next earnings Wed 18 Nov

🔔 Alert▶ Test a strategy

USD billions	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Trend	YoY
Net income	(0.0)	(0.0)	(0.0)	(0.0)	(0.0)	(7.6)		−61414.4%
Depreciation & amortization	0.0	0.0	0.0	0.0	0.0	0.0		—
Stock-based compensation	0.0	0.0	0.0	0.0	0.0	0.1		+21755.4%
Change in working capital	(0.0)	0.0	(0.0)	0.0	0.0	(0.0)		−173.4%
Operating cash flow	(0.0)	(0.0)	(0.0)	(0.0)	(0.0)	(7.8)		−69393.8%
Capital expenditure	0.0	0.0	0.0	0.0	0.0	0.0		—
Acquisitions	0.0	0.0	0.0	0.0	0.0	0.0		—
Investing cash flow	0.0	0.0	0.0	0.0	0.0	0.0		—
Dividends paid	0.0	0.0	0.0	0.0	0.0	0.0		—
Share buybacks	0.0	0.0	0.0	(0.0)	(0.0)	(0.0)		+55.7%
Debt issued / repaid	0.0	0.0	0.0	0.0	0.0	0.0		—
Financing cash flow	0.0	0.0	0.0	0.0	0.0	12.1		+175870.0%
Free cash flow	(0.0)	(0.0)	(0.0)	(0.0)	(0.0)	(7.8)		−69393.8%
Net change in cash	(0.0)	0.0	(0.0)	0.0	(0.0)	4.4		+102060.5%

USD billionsUpdated Wed 13 May ·

ⓘ

Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.

DRMAW · Cash flow · TradingHolo